Skip to main content
Fig. 5 | Pediatric Rheumatology

Fig. 5

From: Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study

Fig. 5

Time course in JADAS-27 scores by a history of receiving bDMARDs. The mean (SD) JADAS-27 scores over time in patients without a history of receiving bDMARDs (a), those with a history of receiving one bDMARD (b), and those with a history of receiving two or more bDMARDs (c) are shown. A paired t-test was used for statistical analysis, with P < 0.05 considered to indicate statistical significance. An asterisk (*) indicates a significant difference was found when compared with baseline. bDMARD, biologic disease-modifying anti-rheumatic drugs; JADAS, Juvenile Arthritis Disease Activity Score; ESR, erythrocyte sedimentation rate

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096